![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Endocrinol. , 14 December 2023
Sec. Clinical Diabetes
Volume 14 - 2023 | https://doi.org/10.3389/fendo.2023.1339588
This article is a correction to:
Quantification of joint mobility limitation in adult type 1 diabetes
A Corrigendum on
Quantification of joint mobility limitation in adult type 1 diabetes
by Phatak S, Mahadevkar P, Chaudhari KS, Chakladar S, Jain S, Dhadge S, Jadhav S, Shah R, Bhalerao A, Patil A, Ingram JL, Goel P and Yajnik CS (2023) Front. Endocrinol. 14:1238825. doi: 10.3389/fendo.2023.1238825
In the published article, there was an error in the Funding statement. The Funding statement acknowledged the funders of this work, however other funders have been supporting patient care. Thus, three philanthropic donors have been added to the statement: Hinduja Foundation, Mukul Madhav Foundation, and Nityasha. The correct Funding statement appears below.
This study is funded through a DBT/Wellcome India Alliance Clinical and Public health fellowship (IA/CPHE/19/504607) awarded to SP. The funding body had no role in study design or analysis. Many participants with type 1 diabetes in this study are beneficiaries of financial and social support from a ‘type 1 diabetes initiative’ of the following philanthropic donors: 1) Hinduja Foundation, 2) Mukul Madhav Foundation, 3) Nityasha. The authors are grateful to these organisations for their continued support in the management of people with type 1 diabetes.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: magnetic resonance imaging (MRI), outcome measure (healthcare), tenosynovitis, metacarpophalangeal (MCP) joint, limited joint mobility (LJM), stiffness
Citation: Phatak S, Mahadevkar P, Chaudhari KS, Chakladar S, Jain S, Dhadge S, Jadhav S, Shah R, Bhalerao A, Patil A, Ingram JL, Goel P and Yajnik CS (2023) Corrigendum: Quantification of joint mobility limitation in adult type 1 diabetes. Front. Endocrinol. 14:1339588. doi: 10.3389/fendo.2023.1339588
Received: 16 November 2023; Accepted: 27 November 2023;
Published: 14 December 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Phatak, Mahadevkar, Chaudhari, Chakladar, Jain, Dhadge, Jadhav, Shah, Bhalerao, Patil, Ingram, Goel and Yajnik. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sanat Phatak, c2FuYXRwaGF0YWtAZ21haWwuY29t
†ORCID: Sanat Phatak, orcid.org/0000-0002-3548-9956
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.